RA-MORPH - Medsafe
NEW ZEALAND DATA SHEET . 1. PRODUCT NAME RA-MORPH ® Morphine Hydrochloride BP Solution 1, 2, 5, and 10 mg/mL. 2. …
Download RA-MORPH - Medsafe
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
Morphine Administration - Auckland District Health …
www.adhb.govt.nzStarship Children’s Health Clinical Guideline Note: The electronic version of this guideline is the version currently in use. Any printed version can
Patient Information (Please Print)
www.mdlab.com*Reflex to antibiotic resistance by Molecular Analysis. ♦Reflex to metronidazole resistance by Real-Time PCR.** Reflex to azithromycin resistance by Pyrosequencing. Ψ Reflex to azithromycin & fluoroquinolone resistance.
attach patient label here Physician Orders ADULT …
www.methodistmd.orgattach patient label here Physician Orders ADULT Order Set: Neuromuscular Blockade of Ventilated Patient Orders [R] = will be orderedT= Today; N …
Orders-23021-QM0908 Ver3 081011 - MethodistMD
www.methodistmd.orgattach patient label here Physician Orders ADULT Height: _____cm Weight: _____kg Allergies: [ ] No known allergies [ ]Medication allergy(s):_____ [ ] Latex allergy ...
NEW PATIENT HEALTH HISTORY AND PAIN …
www.valleypain.orgPATIENT DEMOGRAPHICS . In order to participate in federal and state healthcare programs, our practice requests the demographic information below.
The Impact of Abbreviations on Patient Safety
www.wapatientsafety.orgSeptember 2007 Volume 33 Number 9 577 The Joint Commission Journal on Quality and Patient Safety identified and exported to a worksheet format.
Postoperative care
www.who.intPost operative pain relief • Pain is often the patient’s presenting symptom. It can provide useful clinical information and it is your responsibility to use this information to help the patient and alleviate